M

Marsden Eye Specialists | Parramatta, Australia

Research site
(Unclaimed)
Location
152 Marsden Street, Parramatta, New South Wales, Australia
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

4 of 8
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)

Evaluate the effect of IONIS-FB-LRx on the rate of change of the area of geographic atrophy (GA) secondary to age-related macular degeneration (AMD)...

Active, not recruiting
Macular Degeneration
Geographic Atrophy
Drug: Placebo
Drug: IONIS-FB-LRx

The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with DME.

Enrolling
Diabetic Macular Edema (DME)
Drug: KHK4951
Drug: Aflibercept Injection

The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with nAMD.

Enrolling
Neovascular Age-Related Macular Degeneration (nAMD)
Drug: Aflibercept Injection
Drug: KHK4951

This study will assess a pragmatic, treat and extend regimen of faricimab against the standard of a fixed dosing regimen.

Enrolling
Diabetic Macular Edema
Drug: Faricimab

Trial conditions

Macular Degeneration (3 trials)
Macular Edema (3 trials)
Edema (2 trials)
Atrophy (1 trial)
Colorectal Cancer (1 trial)
Geographic Atrophy (1 trial)
Glaucoma (1 trial)
Hypertension (1 trial)
Ocular Hypertension (1 trial)
Open-Angle Glaucoma (1 trial)

And 1 more

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems